Stay updated on Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.

Latest updates to the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s displayed interface revision was updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than an update to the study details.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.0 to v3.5.2 (adding v3.5.2 and removing v3.5.0).SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedAdded the term 'Severe myoclonic epilepsy in infancy' as a keyword/MeSH term and removed 'Dravet syndrome'.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the site.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded a Publications section with a 2026 NEJM article citation (Zorevunersen in Dravet Syndrome) and PubMed attribution, and noted a revision to version v3.4.3.SummaryDifference0.3%

- Check85 days agoChange DetectedRevision: v3.4.2 was added; older notices about funding lapse and NIH operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.